Nanomedicine Approaches for Corneal Diseases
Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high...
Main Authors: | Shyam S. Chaurasia, Rayne R. Lim, Rajamani Lakshminarayanan, Rajiv R. Mohan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | Journal of Functional Biomaterials |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-4983/6/2/277 |
Similar Items
-
Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases
by: Binapani Mahaling, et al.
Published: (2023-07-01) -
From Nanoparticles to Cancer Nanomedicine: Old Problems with New Solutions
by: Chi-Ling Chiang, et al.
Published: (2021-06-01) -
Keratitis following leech therapy for periocular eczematous dermatitis: a case report
by: Dilek Özkaya
Published: (2023-01-01) -
Application of Nanotechnology in Stem-Cell-Based Therapy of Neurodegenerative Diseases
by: Shima Masoudi Asil, et al.
Published: (2020-07-01) -
NBL1 Reduces Corneal Fibrosis and Scar Formation after Wounding
by: Chi-Hao Tsai, et al.
Published: (2023-10-01)